Coming soon

Abstract submission for ESHG 2027 opens in December 2026

You can already prepare: read the Abstract Submission Guidelines and find the right topic for your abstract below. If you want to apply for an ESHG Conference Fellowship or an Early Career Award, you do this during abstract submission.
Submission opens
December 2026
Deadline: Thursday, 4 February 2027, 23:59 CET
Results: by e-mail by early April 2027

Key rules at a glance

  • One abstract per presenting author. You can be the presenting author of only one abstract. You can be a co-author of any number of abstracts.
  • You can submit for colleagues. One person can submit several abstracts for colleagues who will present them.
  • One person, one e-mail address. The same ESHG account is used for membership, registration, abstract submission and presentation upload. Always use the same e-mail address, and enter your co-authors with the address they use for ESHG.
  • Correct, do not restart. You can change every part of your abstract until the deadline. Never start a new abstract to correct a mistake.
  • No presentation, no publication. Your abstract is published only if it is presented at the conference.

Step-by-step instructions: Abstract Submission Guidelines

Presentation formats

Accepted abstracts are presented in one of three formats:
Oral presentation
You must attend in person
You give a talk at the conference. The talk is also live-streamed, recorded and available on demand on the virtual conference platform.
Hybrid poster
You must attend in person
You present your printed poster at the conference during the “Poster Viewing with Authors” slot. You must also upload a PDF of your poster to the virtual conference platform.
E-poster
You must register · in person or online
You upload your poster as a PDF to the virtual conference platform. You can attend the conference in person or online.
The format depends on the score of your abstract and on the preference you select during submission. Your acceptance e-mail will tell you the format.

How abstracts are selected

Experts in the topic review every abstract and score it on scientific merit. The Scientific Programme Committee uses these scores to build the programme. It assigns abstracts to plenary sessions, concurrent sessions or poster sessions. Please choose your topic carefully, because it decides who reviews your abstract (see “Abstract topics” below).

Acceptance criteria

Abstracts are rejected if:
  • the same person is presenting author of more than one abstract (rejected automatically);
  • the same abstract is submitted more than once with different first authors (rejected automatically);
  • they contain no results or have no structure;
  • their obvious purpose is to advertise commercial products or services;
  • they do not meet ethical standards. This decision is taken by the Scientific Programme Committee (SPC) and the Policy and Ethics Committee (PEC) after a thorough review, following an established procedure.
Work presented or published before (“encore abstracts”) can be submitted. However, it is more likely to be accepted as a poster than as a talk. You must declare it during submission (Step 7).

Publication and data protection

  • Accepted abstracts are published in an electronic supplement of the European Journal of Human Genetics (EJHG) after the conference. This is only possible if the abstract is presented at the conference (in person for talks and hybrid posters, online for e-posters).
  • Accepted abstracts are made public in the conference app two weeks before the conference. Embargoed abstracts are the exception.
  • By submitting an abstract, you agree that ESHG stores and uses your personal data to process the submission, to organise the presentation and to publish the abstract.
Press releases. The Society’s media consultant may select abstracts of special interest to the media for a press release. If your abstract is selected, the consultant will contact you. Work that has already been published elsewhere cannot be selected for a press release.

Abstract topics: where does my abstract fit?

Advances in human genetics have blurred the borders between clinical genetics, cytogenetics and molecular genetics, and between research on monogenic and complex disorders. The abstract topics reflect this. They help researchers who use different approaches to find each other, and we use them to select expert reviewers.

Topics 1–12: groups of conditions

Each topic includes all aspects of these conditions – clinical, cytogenetic and molecular – from basic research to diagnosis and treatment.
  1. Cancer Genetics
  2. Reproductive Genetics
  3. Prenatal Genetics
  4. Sensory Disorders (Eye, Ear, Pain)
  5. Internal Organs and Endocrinology
  6. Skeletal, Connective Tissue, Ectodermal and Skin Conditions
  7. Cardiovascular Conditions
  8. Inborn Errors of Metabolism
  9. Immunology and Hematopoietic System
  10. Intellectual Disability
  11. Neurogenetic and Psychiatric Conditions
  12. Neuromuscular Conditions

Topics 13–26: approaches and themes across conditions

  1. Multiple Malformation/Anomalies Syndromes Complex syndromes and cytogenetic disorders with multiple symptoms.
  2. Cytogenetics, Genome Variation and Architecture Genomic variation and genome structure not necessarily linked to a specific phenotype (e.g. splicing mechanisms, origin of ring chromosomes); studies of chromosome and genome architecture.
  3. Bioinformatics, Statistical Methods and AI Bioinformatics, machine learning and statistical approaches in genomics and other -omics.
  4. Large-Scale Genomics (GWAS) and Other -Omics Association Studies Genetics of complex diseases and traits; GWAS results for rare and common variants; functional follow-up of GWAS; large-scale association studies based on other -omics data (e.g. metabolomics, proteomics).
  5. Genetic Epidemiology (e.g. Mendelian Randomization) The role of genomics and other -omics in personalised medicine, epidemiology and public health, and improved methods for these studies, including Mendelian randomisation.
  6. Pharmacogenomics and Drug Repurposing Genetics and genomics of drug response, including adverse reactions; repurposed or off-label use of existing drugs for (common) genetic diseases. For drug repurposing in a specific rare disease, Topic 24 may fit better.
  7. Population Genetics and Evolutionary Genetics Population genetics and evolutionary genetics.
  8. Genomics of Rare Diseases Work relevant to many rare diseases, not to one specific phenotype (unlike Topics 1–12), e.g. new technologies for rare disease research and diagnostics, or analyses of large, mixed cohorts of rare diseases.
  9. Wet & Dry Lab Improvements for Diagnostics General technical approaches and quality control in genetic diagnostics and research.
  10. Functional Genomics Biology and function of the genome, including epigenetics.
  11. New Technologies Brand-new concepts or genomic technologies, and the evaluation of their potential.
  12. Treatments for Genetic Disorders New therapeutic options for genetic disorders.
  13. Genetic Counselling / Services / Education Genetic counselling, education and public services.
  14. Ethical, Legal and Psychosocial Aspects in Genetics Psychological, ethical and legal issues in genetics.